Revenue Recognition |
Revenue Disaggregated Revenue
The following table presents the Company’s disaggregated revenue by offering type (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
2023 |
|
2022 |
|
2021 |
|
Total Net
Revenues
|
|
% of
Total Net
Revenues
|
|
Total Net
Revenues
|
|
% of
Total Net
Revenues
|
|
Total Net
Revenues
|
|
% of
Total Net
Revenues
|
Patient Services revenue recognized at a point in time: |
|
|
|
|
|
|
|
|
|
|
|
Direct products |
$ |
2,294 |
|
|
1.8 |
% |
|
$ |
2,236 |
|
|
2.0 |
% |
|
$ |
2,480 |
|
|
2.4 |
% |
Third-Party Payer products |
13,821 |
|
|
11.0 |
% |
|
12,573 |
|
|
11.4 |
% |
|
12,112 |
|
|
11.8 |
% |
Patient Services revenue recognized over time: |
|
|
|
|
|
|
|
|
|
|
|
Direct rental services |
7,388 |
|
|
5.9 |
% |
|
7,246 |
|
|
6.6 |
% |
|
7,333 |
|
|
7.2 |
% |
Third-Party Payer rental services |
44,475 |
|
|
35.4 |
% |
|
40,948 |
|
|
37.3 |
% |
|
38,765 |
|
|
37.9 |
% |
Total Patient Services accounted for under ASC 606 |
67,978 |
|
|
54.1 |
% |
|
63,003 |
|
|
57.3 |
% |
|
60,690 |
|
|
59.3 |
% |
Device Solutions revenue recognized at a point in time: |
|
|
|
|
|
|
|
|
|
|
|
Products |
14,877 |
|
|
11.8 |
% |
|
15,359 |
|
|
14.0 |
% |
|
15,296 |
|
|
14.9 |
% |
Services |
9,844 |
|
|
7.8 |
% |
|
6,434 |
|
|
5.9 |
% |
|
4,718 |
|
|
4.6 |
% |
Device Solutions revenue recognized over time: |
|
|
|
|
|
|
|
|
|
|
|
Services |
6,038 |
|
|
4.8 |
% |
|
633 |
|
|
0.6 |
% |
|
— |
|
|
— |
% |
Total Device Solutions accounted for under ASC 606 |
30,759 |
|
|
24.4 |
% |
|
22,426 |
|
|
20.5 |
% |
|
20,014 |
|
|
19.5 |
% |
Total Revenue Accounted for under ASC 606 |
98,737 |
|
|
78.5 |
% |
|
85,429 |
|
|
77.8 |
% |
|
80,704 |
|
|
78.8 |
% |
Patient Services Lease Revenue |
8,563 |
|
|
6.8 |
% |
|
5,878 |
|
|
5.3 |
% |
|
4,908 |
|
|
4.8 |
% |
Device Solutions Lease Revenue |
18,485 |
|
|
14.7 |
% |
|
18,607 |
|
|
16.9 |
% |
|
16,770 |
|
|
16.4 |
% |
Total Revenue accounted for under ASC 842, Leases |
27,048 |
|
|
21.5 |
% |
|
24,485 |
|
|
22.2 |
% |
|
21,678 |
|
|
21.2 |
% |
Total Net Revenue |
$ |
125,785 |
|
|
100.0 |
% |
|
$ |
109,914 |
|
|
100.0 |
% |
|
$ |
102,382 |
|
|
100.0 |
% |
Contract Balances
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
2022 |
|
2021 |
|
Change in 2023 |
|
Change in 2022 |
Accounts receivable, net |
$ |
19,830 |
|
|
$ |
16,871 |
|
|
$ |
15,405 |
|
|
$ |
2,959 |
|
|
$ |
1,466 |
|
Contract assets |
$ |
1,271 |
|
|
$ |
360 |
|
|
$ |
— |
|
|
$ |
911 |
|
|
$ |
360 |
|
The change in contract assets during the fiscal year ended December 31, 2023 was mainly due to $9.2 million of revenue recognized for which the payment is subject to conditions other than the passage of time, partially offset by $8.3 million of contract assets reclassified to accounts receivable as our right to consideration for these contract assets became unconditional. Contract assets are included in other current assets on the Company's Consolidated Balance Sheets.
|